ESMO Breast Cancer 2023 Congress Coverage

 

Videos
19:34

ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Clinical Impact of Evolving ADC Technology

FEATURING Heather McArthur
  • 140 views
  • June 14, 2023
  • 2
10:48

ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Results of Part B of SOLTI TOT-HER3 Window of Opportunity Trial: Patritumab Deruxtecan in HR+/HER2- & TNBC

FEATURING Mafalda Oliveira
  • 296 views
  • May 31, 2023
  • 2
16:20

ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023: Role of Germline Genetic Testing in Early Breast Cancer for Therapeutic Purposes

FEATURING Soo Chin Lee
  • 91 views
  • May 31, 2023
  • 1
07:49

ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients Who Discontinued Chemo Before Pembro and in Patients With Immune-Mediated AEs

FEATURING Hope Rugo
  • 849 views
  • May 25, 2023
  • 7
17:44

ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Phase 3 DESTINY-Breast04 Trial Safety Analysis: T-DXd vs. TPC in HER2-Low Unresectable and/or Metastatic BC

FEATURING Hope Rugo
  • 39 views
  • May 25, 2023
14:38

ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Phase 3b LUCY Trial Subgroup Analysis: Clinical Effectiveness of Olaparib in BRCAm, HER2- mBC by ER Expression Level

FEATURING Karen Gelmon
  • 98 views
  • May 25, 2023
  • 2
17:03

ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Clinical Implementation of Oral SERD: Present & Future

FEATURING Carmen Criscitiello
  • 240 views
  • May 25, 2023
  • 2
10:06

ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 DORA Phase 2 Study: Durvalumab and Olaparib in Platinum-Treated Advanced TNBC

FEATURING Tira Tan
  • 42 views
  • May 24, 2023
14:11

ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Highlights: Key Studies Including IMPassion031 & ICARUS-BREAST01

FEATURING Paolo Tarantino
  • 753 views
  • May 22, 2023
  • 5
16:58

ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023: Who Really Benefits From IO? Can We Identify Subsets That Benefit and How to Measure?

FEATURING Justin Balko
  • 37 views
  • May 22, 2023
09:56

ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 EMERALD Trial: Analysis of PROs in Patients With ER+/HER2- Advanced or Metastatic BC Comparing Oral Elacestrant vs. Standard of Care ET

FEATURING Javier Cortes
  • 484 views
  • May 22, 2023
05:47

ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 DATA Trial Analysis: The Prognostic and Predictive Effect of BMI in Postmenopausal HR+ BC Patients Receiving (Extended) Endocrine Therapy

FEATURING Senna Lammers
  • 47 views
  • May 18, 2023